Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-26

Clinical Trial Update: ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing ACP-196 to placebo in rheumatoid arthritis patients on background methotrexate has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACP-196 (acalabrutinib)

Snippet

Sponsor: Acerta Pharma BV | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2019-03-26